发明名称 |
Composition for prevention or treatment of cancer comprising N-methylenenaphtho[2,1-<i>b</i>]furan-2-carbohydrazide derivatives as an active ingredient |
摘要 |
The present invention relates to ethyl(2-methyl-3{(E)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1H-indole-1-yl)acetate, the novel mitosis inhibitor. The said ethyl(2-methyl-3{(E)-[(naphtho[2,1-b]furan-2-ylcarbonyl)hydrazono]methyl}-1H-indole-1-yl)acetate not only induces apoptosis by inhibiting tubulin polymerization in the course of mitosis but also displays an excellent anticancer effect in the multi-drug resistant cancer cells, so that it can be effectively used for the treatment of cell proliferative disease including various cancers. |
申请公布号 |
US9433607(B2) |
申请公布日期 |
2016.09.06 |
申请号 |
US201514641065 |
申请日期 |
2015.03.06 |
申请人 |
Korea Research Institute of Bioscience and Biotechnology |
发明人 |
Kim Bo Yeon;Sakchaisri Krisada;Kim Sun Ok;Naraganahalli Ramegowda Thimmegowda;Soung Nak Kyun;Ahn Jong Seog;Hwang Joonsung;Ryoo In Ja;Jang Jae-Hyuk |
分类号 |
A61K31/40;A61K31/405;A61K31/34;A61K31/343;A61K31/4045 |
主分类号 |
A61K31/40 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. A method of treating cancer, comprising administering a pharmaceutically effective dose of a compound represented by the below formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient to a subject having cancer: wherein R1 is wherein R2 is methyl, R3 is methyl, allyl, cyanomethyl or —CH2(C═O)OCH2CH3, and R4 is nitro, 4-bromophenyl, 2,3-dichlorophenyl, 4-nitrophenyl or 4-methyl-3-nitrophenyl. |
地址 |
Daejeon KR |